Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat in pediatric anemia of chronic kidney disease
NCT05082571Phase 3Withdrawn
- Sponsor
- Akebia Therapeutics
- Start
- Jan 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Planned start Jan 2025; status: withdrawn.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT05082571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082571.